by In2Pharma | Jan 26, 2022 | News
Europe From 28 January 2022, new regulations will come into force for manufacturers, importers and distributors of medicines for human and veterinary use. The National Competent Authorities (FAMHP / Farmatec) is asking them to check from 28 January 2022 onwards...
by In2Pharma | Jan 26, 2022 | News
The Netherlands The Medicines Evaluation Board (MEB) has revised two policy documents for pharmaceutical companies on the requirements for product information: MEB 5: Package leaflet of pharmaceutical products Update sections 4, 5.1, 6, 6.2, 7, 7.1, 7.4.1 Update Annex...
by In2Pharma | Nov 3, 2021 | News
The Netherlands The remuneration for services provided by healthcare professionals (HCPs) should be proportionate to the services rendered. In order to ensure this, maximum hourly rates are imposed. From January 1, 2022, these maximum hourly rates will be indexed. The...
